Business

DOMA Perpetual Director Nominees Send Letter to Shareholders of Pacira Biosciences

DOMA Perpetual Capital Management ("DOMA Perpetual") which, together with its affiliates (collectively "DOMA" or "we"), beneficially owns approximately 7.5% of the outstanding shares of common stock of Pacira BioSciences, Inc. (NASDAQ: PCRX) ("Pacira" or the "Company") announced that the two independent, highly qualified members of DOMA's three-person slate of nominees for election to the Company's board of directors have released a joint letter to Pacira stockholders.

articlePacira Biosciences, Inc.May 20, 202612/company/pacira-biosciences-inc/news/doma-perpetual-director-nominees-send-letter-to-shareholders-of-pacira-biosciences
DOMA Perpetual Director Nominees Send Letter to Shareholders of Pacira Biosciences

About this update from Pacira Biosciences, Inc.

[{"type":"text","content":"Independent Directors, Christopher Dennis, MD, MBA, FAPA and Oliver Benton "Ben" Curtis III Outline How Their Skills and Experience Will Drive Positive Change","length":168,"tagName":"p","attribs":{}},{"type":"text","content":"Intend to Work Collaboratively with Incumbent Directors to Strengthen Oversight and Create Value for All Shareholders","length":117,"tagName":"p","attribs":{}},{"type":"text","content":"Encourage Shareholders to Support Meaningful Board Change by Voting via the WHITE Proxy Card for DOMA's Three Nominees","length":122,"tagName":"p","attribs":{}},{"type":"text","content":"MIAMI, May 20, 2026 /PRNewswire/ -- DOMA Perpetual Capital Management ("DOMA Perpetual") which, together with its affiliates (collectively "DOMA" or "we"), beneficially owns approximately 7.5% of the outstanding shares of common stock of Pacira BioSciences, Inc. (NASDAQ: PCRX) ("Pacira" or the "Company") announced that the two independent, highly qualified members of DOMA's three-person slate of nominees for election to the Company's board of directors have released a joint letter to Pacira stockholders.","length":567,"tagName":"p"},{"type":"image","alt":"DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual)","displaySize":"","headline":null,"caption":"DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":118,"url":"https://media.zenfs.com/en/prnewswire.com/1e8ded2293e965ad361d9ce30d6866e3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/NgKCrMfj16DkteLv.vpYsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIwOA--/https://media.zenfs.com/en/prnewswire.com/1e8ded2293e965ad361d9ce30d6866e3","width":400,"height":118},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/M5.Yxu79WNVQQZU3S_9XEQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE4OQ--/https://media.zenfs.com/en/prnewswire.com/1e8ded2293e965ad361d9ce30d6866e3","width":400,"height":118}},"href":"https://mma.prnewswire.com/media/2468496/DOMA_Perpetual_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The letter can be downloaded here","length":38,"tagName":"p"},{"type":"text","content":"The full text of the letter follows:","length":36,"tagName":"p"},{"type":"text","content":"A LETTER TO PACIRA B...

More updates from Pacira Biosciences, Inc.

DOMAPacira BioSciences, Inc.DOMA Perpetual Capital ManagementCHRISTOPHER DENNISstockholdersCompanyPacira